Leveque Joseph 4
4 · Synthorx, Inc. · Filed Jan 2, 2020
Insider Transaction Report
Form 4
Synthorx, Inc.THOR
Leveque Joseph
Chief Medical Officer
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2019-12-30−75,000→ 42,000 totalExercise: $11.00Exp: 2028-12-05→ Common Stock (75,000 underlying) - Exercise/Conversion
Common Stock
2019-12-30$11.00/sh+75,000$825,000→ 358,910 total - Tax Payment
Common Stock
2019-12-30$70.63/sh−45,019$3,179,692→ 313,891 total
Footnotes (1)
- [F1]75,000 shares subject to the option are vested. The remainder of the shares subject to the option vest upon certification by the Compensation Committee of the Board of Directors of the Issuer that the Issuer has received the first approval for commercial sale by a regulatory authority of any product candidate of the Issuer in any territory in the world.